Trial
NCT00937417
S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
SWOG Cancer Research Network
Collaborators
National Cancer Institute (NCI)
Condition
Breast Cancer
Intervention
docetaxel
Why stopped
Withdrawn because SWOG no longer pursuing this study at this time
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-24